ArticleJournal of global health2025
India's death toll in 2021 during the COVID-19 pandemic: insights from delayed official civil registration data.
Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
India released its 2021 official death registration data in May 2025, showing a dramatic undercount of reported COVID-19 mortality in 2021 - a year that included the lethal second wave from the Delta variant in April to June 2021. The civil registration system (CRS) documented 10.2 million deaths in 2021 - a 26% increase from 2020 - compared to only 335 004 reported COVID-19 deaths. We calculated excess deaths as the difference between observed deaths and expected deaths had pre-pandemic mortality trends continued. Our analysis reveals India experienced approximately 2.4 million excess deaths in 2021, representing a 7.2× undercount compared to reported COVID-19 deaths. This aligns with the estimates derived from several epidemiological models during and after the pandemic, indicating excess-to-reported COVID-19 death ratios ranging from 4.4× to 11.9×. State-level analyses revealed considerable variation in reporting fidelity, with excess-to-COVID-19 death ratios ranging from under 2× in Kerala and Goa to over 40 in Gujarat. Limited disaggregated data showed excess death rates were substantially higher in men than women (2.2 vs. 1.3 per 1000 population), and in urban than rural areas (2.3 vs. 1.4 per 1000 population). Since the CRS data are incomplete in terms of age-stratified deaths, the proportional allocation of deaths by age according to external sources suggests excess death rates were higher in the 65 and older age group than in the population under 65 (14.1 vs. 0.9 per 1000 population). The four-year data delay and systematic underreporting underscore urgent needs for modernising India's surveillance system during acute phases of the pandemic and restructuring the official vital registration systems through protocol standardisation, real-time linkages, and infrastructure investments. Robust mortality tracking strengthens crisis preparedness and broader public health response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.